Alembic Pharmaceuticals Limited - Press Release

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 06, 2019, titled Alembic Pharmaceuticals receives USFDA Approval for Carbidopa and Levodopa Extended-Release Tablets USP, 25 mg/100 mg and 50 mg/200 mg..

Jun 05, 2019 06:06 IST capital market

Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated Jun 06, 2019, titled Alembic Pharmaceuticals receives USFDA Approval for Carbidopa and Levodopa Extended-Release Tablets USP, 25 mg/100 mg and 50 mg/200 mg..

Related Story